-
Pioneering PharmaceuticalSALK Antibodies and Opdivo Second-Line Treatment HCC Data Bright: Objective Remission Rate 40%
Time of Update: 2021-01-16
American Society of Clinical Oncology (ASCO GI) Gastrointestinal Oncology Symposium (ASCO GI). results show that the efficacy of combination therapy is encouraging and safe. 2021 ASCO GI will be held from January 15-17, 2021 local time
-
Repotrectinib was again awarded the breakthrough therapy title for the treatment of ROS1-positive metastasis NSCLC
Time of Update: 2021-01-16
Turning Point Therapeutics Inc. announced on December 8 that its candidate drug for ROS1-positive metastasis non-small cell lung cancer (NSCLC), which has not been treated with ROS1 tyrosine kinase inhibitors (TKI-naïve), has been named
-
Research and development daily Roche CD20× CD3 dual anti-first-line treatment DLBCL full remission rate of 79%
Time of Update: 2021-01-16
Phase ANCHOR Joint Study; Pfizer Releases CD3 Dual Anti-Treatment Multiple Myeloma Phase I Data; Cochrane Bio23 Price Pneumonia Vaccine Approved in China; Amgen KRAS Inhibitor Identified by FDA Breakthrough Therapy; Alzheimer's New Target Path - Drp1-HK1-NRP3...
-
Treatment of ulcerative colitis AbbVie JAK inhibitors reaches phase 3 clinical end
Time of Update: 2021-01-16
AbbVie today announced that its JAK inhibitor, upadacitinib, has reached the primary endpoint of clinical remission and all critical secondary endpoints in Phase 3 clinical trials for adult patients treating moderate ulcerative colitis.
-
Kozi bioCT053 all-human anti-BCMA CAR T cell injections were incorporated into the breakthrough treatment variety
Time of Update: 2021-01-16
On December 8, Kozi Bio announced that its CT053 all-human anti-BCMA in vitro CAR T cell injection was incorporated into the breakthrough therapeutic drug variety through the CDE publicity period, and that the adaptive disorder was formulated
-
Neurology: Beijing Tiantan Hospital found: intracranial ruptured small aneurysm, aspirin treatment is safe and effective
Time of Update: 2021-01-16
of the study is to find that aspirin is a safe treatment for patients with both small UIAs and ICVD.
-
Three new Class 1 drugs are intended to be included in the breakthrough treatment varieties from Keystone, Microcore Biology and Dijon
Time of Update: 2021-01-16
license for the product in Greater China in June 2018. July, Blueprint Medicines also launched a global partnership with Roche (in addition to Greater China) to develop and commercialize pralsetinib for the treatment of RET mutation cancer
-
Hengrui Pharmaceutical two new drugs are intended to be included in the breakthrough treatment varieties of two drugs combined to treat cervical cancer
Time of Update: 2021-01-16
China's State Drug Administration Drug Review Center (CDE) website recently announced that Hengrui Pharmaceutical two new drugs are intended to be included in the breakthrough treatment varieties, respectively, PD-1 inhibitor injection karili pearl
-
Talk about the prevention and treatment of common defects of water-based anti-corrosion coatings
Time of Update: 2021-01-15
varieties have been increased to more than a dozen. At present, the development of water-powered auto parts paint has begun. The company's high-level strategy is: solvent-based coatings gradually reduce VOC and other harmful substances, water-based anti
-
The domestic listing application for the new crown vaccine of The Chinese medicine was accepted, and the Phase III clinical treatment continued
Time of Update: 2021-01-15
health supervision authority in Bahrain on the 13th of this month, officially approved The Chinese National Pharmaceutical Group developed a new crown inactivated vaccine registered in Bahrain.
-
Nat Med: Cancer cells can get worse when they spread to the liver, and the team reveals the reasons behind it and proposes treatments
Time of Update: 2021-01-15
study showed that hepatic metastasis tumors can use the host's external immune tolerance mechanism to develop access to immunotherapy resistance through the absence of CD8-T cells.
-
Fluorocarbon coating pre-treatment process control points
Time of Update: 2021-01-15
If the flowing film is uniform and there are no gaps, the aluminum plate has been cleaned.
-
Clin Gastroenterology H: Reducing the duration of use of Usnu monoantigen can improve the effectiveness of treatment for Crohn's disease
Time of Update: 2021-01-15
the study, researchers confirmed that reducing the interval between usanu monoantigens to four weeks for non-responsive CD patients at 90 mg per 8 weeks could improve clinical and biological indicators of disease activity.
-
Science|。 New concept: a systematic review of the treatment of cancer when refined
Time of Update: 2021-01-15
and repair plays an important role in the development of UV-induced skin cancer, as well as in the functioning of Pt-based chemotherapy drugs. repair has a very strong circadian rhythm regulation, and its activity stage depends primarily
-
And yellow medicine second treatment of advanced non-pancreatic neuroendocrine tumor new drug approved in sight
Time of Update: 2021-01-15
, Sovantini's application for adaptation to the treatment of advanced non-pancreatic neuroendocrine tumors is based on data from clinical studies SANET-ep.
-
Today Rongchang bio-anti-HER2 antibody association drugs are to be included in the breakthrough treatment varieties
Time of Update: 2021-01-15
Rongchang Bio plans to submit to China's State Drug Administration in the first half of 2021 vidicido single anti-treatment of urethra skin cancer new drug market applications.
-
China NMPA receives the NDA of Envafolimab (KN035) for the treatment of MSI-H/dMMR advanced solid tumors
Time of Update: 2021-01-15
Biopharmaceutical company TRACON announced today that China's State Drug Administration (NMPA) has accepted a new drug application (NDA) from Envafolimab (KN035) for the treatment of MSI-H/dMMR advanced solid tumors.
-
Coating wastewater treatment process
Time of Update: 2021-01-15
/L. Zhao Xue and other processes using gas floating pool and two-stage aeration biofiltration pool to treat paint wastewater, but also achieved good results. 1, engineering examples 1.1 wastewater quality, water quantity
-
FDA awards Ilixadencel 'orphan drug' for treatment of hepatocellular carcinoma (HCC)
Time of Update: 2021-01-14
, a pharmaceutical company, recently announced that the U.S. Food and Drug Administration (FDA) has awarded Ilixadencel the "Orphan Drug Title" (ODD) for the treatment of hepatocellular carcinoma (HCC).
-
Lynparza is approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers
Time of Update: 2021-01-14
AstraZeneza and MSD's Lynparza (olaparib) have been approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers. specific information on these three approvals: patients with HRD recombinant repair defects (HRD
